Thomas U. Marron

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Thomas U. Marron

Sep 12, 2024, 14:29 | Insight

Patrick Hwu: The mechanism behind increased IL-1 production and cancer progression

Patrick Hwu shared a post on LinkedIn: “Cancer incidence increases with age, but what is…

Sep 4, 2024, 10:54 | Insight

Article of the day, September 4th, suggested by the Immune Oncology Research Institute

Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…

Jul 24, 2024, 08:58 | Opinion

Hepatic decompensation and mortality in HCC treated with atezo-beva

Erman Akkus, Medical Oncologist at Ankara University, shared on X about an article titled "Hepatic…

Jul 22, 2024, 15:02 | Insight

Immunotherapy use and effectiveness in Child-Pugh class B

JAMA Oncology shared a post on X about a paper titled "Immunotherapy vs Best Supportive…

Jul 14, 2024, 15:02 | Insight

Bruno Giotti: Multiple gene programs and cellular subpopulations associated with patient prognosis in pleural mesothelioma

Bruno Giotti, Postdoctoral Researcher at Icahn School of Medicine at Mount Sinai, shared a post…

Jul 7, 2024, 16:08 | Insight

Tumor Microenvironment Gradients in Pleural Mesothelioma

Elizabeth McKenna shared on X: "Now online in Cancer Discovery: Single-cell View of Tumor Microenvironment Gradients…

Apr 10, 2024, 09:32 | Insight

New Article Alert! New Findings on Personalized Vaccine and Pembrolizumab for Liver Cancer Treatment

New Findings on Personalized Vaccine and Pembrolizumab for Liver Cancer Treatment Authors: Mark Yarchoan, Edward…

All: 7 Posts: 1 - 100